TB and HIV/AIDS
From CDC's Division of HIV/AIDS Prevention
Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
From CDC's Division of Tuberculosis Elimination
MMWR: Reported HIV Status of Tuberculosis Patients—United States, 1993–2005
From CDC’s MMWR Weekly October 26, 2007 / 56(42);1103-1106
HIV Testing and Counseling in TB Clinical Settings Tools
From CDC’s Global AIDS Program
Recommendations for Human Immunodeficiency Virus (HIV) Screening in Tuberculosis (TB) Clinics
From CDC’s Division of Tuberculosis Elimination
Risk-Based Targeted Tuberculosis Screening in Virginia
Policy summary, including core components and outcome information, on a TB screening policy implemented by the Virginia Department of TB Control from the Best Practice Initiative of the US Department of Health and Human Services
Treatment of Tuberculosis (Joint statement from the American Thoracic Society, CDC, and Infectious Diseases Society of America)
MMWR: June 20, 2003 / Vol. 52 / RR-11
Mantoux Tuberculin Skin Test Training Materials Kit
Material available from the Division of TB Elimination (DTBE) of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
QuantiFERON ®-TB Gold Test
From DTBE
Guidelines for Using the QuantiFERON ®-TB Test for Diagnosing LatentMycobacterium tuberculosisInfection
From the CDC’sMMWR Recommendations and Reports January 31, 2003 / Vol. 52 (RR-02); 15-18
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
[HTML] [PDF]
From CDC’s MMWR Recommendations and Reports, June 9, 2000; 49 (No. RR-6)
Anergy Skin Testing and Preventive Therapy for HIV-Infected Persons: Revised Recommendations
From CDC’s MMWR Recommendations and Reports , September 5, 1997, 46 (RR-15)
The Role of BCG Vaccine in the Prevention and Control of Tuberculosis in the U.S.
From CDC’s MMWR Recommendations and Reports , April 26, 1996, 45 (RR-4)
Screening for Tuberculosis and Tuberculosis Infection in High-Risk Populations (ACET)
From CDC’s MMWR Recommendations and Reports, 1995; 44 (No. RR-11)
Guide for Primary Health Care Providers: Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection 2005
From DTBE
TB Testing Guidelines
From DTBE
Tuberculin Skin Testing
From DTBE
Mantoux Tuberculin Skin Test Videotape Facilitator Guide
From DTBE
Diagnosis of Tuberculosis Disease
From DTBE
Slide Set Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection, 2005
From DTBE
TB Treatment Guidelines
From DTBE
TB Treatment Guidelines in PDA Format
From DTBE
Slide Set Treatment of Tuberculosis
From DTBE
Treatment of Drug-Resistant Tuberculosis
Fact sheet From DTBE
Treatment of Latent Tuberculosis Infection (LTBI)
Fact sheet from DTBE
Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
From DTBE
BCG Vaccine
From DTBE
Tuberculosis and Pregnancy
From DTBE
Treatment Outcomes for Patients with Multidrug-Resistant Tuberculosis
From the Annals of Internal Medicine, 2 May 2006 | Volume 144 Issue 9 | Page I-18
Treatment of Tuberculosis in Patients Infected with HIV: An Update
FromNew JerseyAIDSline Volume 2 Number 1, September 2005
Diagnosis and Treatment Resources
From the New Jersey Medical School Global Tuberculosis Institute
Management of Latent Tuberculosis Infection in Children and Adolescents: A Guide for the Primary Care Provider: 2004
From New Jersey Medical School Global Tuberculosis Institute
Treatment of Tuberculosis Infection and Disease
From the New Jersey Medical School Global Tuberculosis Institute
Treating The Patient With Tuberculosis: Guidelines For Collaborating With Community Physicians
From the New Jersey Medical School Global Tuberculosis Institute, designed for use by state and local health departments
